Ewing's sarcoma family tumours: Differences in clinicopathological characteristics at presentation between localised and metastatic tumours

G. Bacci, A. Balladelli, C. Forni, A. Longhi, M. Serra, N. Fabbri, M. Alberghini, S. Ferrari, M. S. Benassi, P. Picci

Research output: Contribution to journalArticle

Abstract

Despite local treatment with systemic chemotherapy in Ewing's sarcoma family tumours (ESFT), patients with detectable metastases at presentation have a markedly worse prognosis than those with apparently localised disease. We investigated the clinical, pathological and laboratory differences in 888 patients with ESFT, 702 with localised disease and 186 with overt metastases at presentation, seen at our institution between 1983 and 2006. Multivariate analyses showed that location in the pelvis, a high level of serum lactic dehydrogenase, the presence of fever and a short interval between the onset of symptoms and diagnosis were indicative of metastatic disease. The rate of overt metastases at presentation was 10% without these four risk factors, 22.7% with one, 31.4% with two, and 50% for those with three or four factors. We concluded that in ESFT the site, the serum level of lactic dehydrogenase, fever, and the interval between the onset of symptoms and diagnosis are indicators of tumours having a particularly aggressive metastatic behaviour.

Original languageEnglish
Pages (from-to)1229-1233
Number of pages5
JournalJournal of Bone and Joint Surgery - Series B
Volume89
Issue number9
DOIs
Publication statusPublished - Sep 2007

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Ewing's sarcoma family tumours: Differences in clinicopathological characteristics at presentation between localised and metastatic tumours'. Together they form a unique fingerprint.

  • Cite this